Bruttis, can you explain the 'wrong direction'? Wouldnt a recommended stock attract more buyers, who want 'in' while the price is climbing up?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025